5-Fluorocytosine in the treatment of candidiasis with acute renal insufficiency: its kinetics during haemodialysis and peritoneal dialysis.
D058186:Acute Kidney Injury / Q000150:complications*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001002:Anuria / Q000150:complications; D001711:Biotransformation; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy; D003596:Cytosine / Q000627:therapeutic use*; D004231:Diuresis / Q000187:drug effects; D005260:Female; D005437:Flucytosine / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D010530:Peritoneal Dialysis; D006435:Renal Dialysis; D013223:Statistics as Topic
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine